Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Japanese B”

72 trials

Showing 20 of 72 results

Post-approval studies (Phase 4)Study completedNCT02532569
What this trial is testing

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 94
Large-scale testing (Phase 3)Study completedNCT00595309
What this trial is testing

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 198
Large-scale testing (Phase 3)Study completedNCT00412516
What this trial is testing

Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

Who this might be right for
Encephalitis, Japanese B
PATH 519
Testing effectiveness (Phase 2)Study completedNCT02816554
What this trial is testing

Safety and Immunogenicity of JECEVAX in Young Children

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 200
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Large-scale testing (Phase 3)Study completedNCT00776230
What this trial is testing

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 304
Testing effectiveness (Phase 2)Study completedNCT00981175
What this trial is testing

ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi 202
Large-scale testing (Phase 3)Study completedNCT00594958
What this trial is testing

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 639
Testing effectiveness (Phase 2)Study completedNCT00981630
What this trial is testing

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis
Sanofi 128
Large-scale testing (Phase 3)Study completedNCT00314145
What this trial is testing

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Who this might be right for
Japanese Encephalitis
Sanofi 820
Testing effectiveness (Phase 2)Study completedNCT01856205
What this trial is testing

Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

Who this might be right for
Japanese Encephalitis
University of Liverpool 22
Testing effectiveness (Phase 2)Study completedNCT00441259
What this trial is testing

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Who this might be right for
Japanese Encephalitis
Sanofi 96
Not applicableStudy completedNCT02933710
What this trial is testing

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 50
Large-scale testing (Phase 3)UnknownNCT04223037
What this trial is testing

Purified Inactivated Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis Virus Disease
Chinese Academy of Medical Sciences 1,050
Large-scale testing (Phase 3)Study completedNCT01408537
What this trial is testing

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

Who this might be right for
Encephalitis, Japanese B
Mahidol University 152
Large-scale testing (Phase 3)Study completedNCT00314132
What this trial is testing

Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi 2,004
Not applicableStudy completedNCT02602652
What this trial is testing

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Who this might be right for
Japanese Encephalitis
Chulalongkorn University 50
Post-approval studies (Phase 4)Study completedNCT00463476
What this trial is testing

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

Who this might be right for
Japanese Encephalitis
PATH 305
Large-scale testing (Phase 3)Study completedNCT00249769
What this trial is testing

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

Who this might be right for
Encephalitis, Japanese B
PATH 600
Large-scale testing (Phase 3)Study completedNCT01396512
What this trial is testing

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

Who this might be right for
Japanese EncephalitisJapanese Encephalitis Virus Disease
Sanofi Pasteur, a Sanofi Company 274
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation